Steven Gabe Davis MD FACP

Infectious Disease•Grapevine, TX

HIV/AIDS Medicine, Transplant/Immunocompromised States, Clinical Pharmacology, Clinical Informatics

DALLAS ID ASSOCIATES

Join to View Full Profile

1600 W College StSuite 130Grapevine, TX 76051
Phone+1 214-689-7806
Fax+1 214-689-5970

Summary

Dr. Steven Davis is an infectious disease specialist in Irving, TX and is affiliated with multiple hospitals in the area, including Medical City Las Colinas, Baylor Regional Medical Center at Grapevine, Medical City Denton, Baylor Scott & White Medical Center-Irving, and Medical City Dallas. He received his medical degree from Indiana University School of Medicine and has been in practice 31 years. He specializes in hiv/aids medicine, healthcare associated infections, and transplant/immunocompromised states.

Education & Training

University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 1989 - 1991
Indiana University School of MedicineResidency, Internal Medicine, 1986 - 1989
Indiana University School of MedicineClass of 1986

Certifications & Licensure

TX State Medical License 1990 - 2027
FL State Medical License 2020 - 2026
NY State Medical License 1998 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2022-2023
Top Doctor Dallas D Magazine, 2021, 2023
Fellow (FACP) American College of Physicians, 2003
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation Start of enrollment: 2020 Sep 14
Completed
Phase 1, Phase 2
Growth Hormone in the Treatment of HIV-Associated Wasting Start of enrollment: 1997 Jul 01
Completed
Phase 3
A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
Completed
Phase 2
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
Completed
Phase 3
A Study of 1592U89 in HIV-Infected Adults
Completed
Not Applicable
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
Completed
Phase 3
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
Unknown status
Phase 4
A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive
Completed
Not Applicable
Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections Start of enrollment: 2001 Apr 01
Completed
Phase 3
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness Start of enrollment: 2020 Oct 29
Completed
Phase 2
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness Start of enrollment: 2020 Jun 17
Completed
Phase 2, Phase 3
A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia Start of enrollment: 2020 Jun 16
Completed
Phase 3
A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) Start of enrollment: 2020 Apr 15
Completed
Phase 2
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants Start of enrollment: 2020 Sep 07
COMPLETED
PHASE3
Join now to see all

Publications & Presentations

PubMed

21 citations
Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.
Gerard J Criner, Frederick M Lang, Robert L Gottlieb, Kusum S Mathews, Tisha S Wang
American Journal of Respiratory and Critical Care Medicine. 2022-06-01
3 citations
Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19.
Cindy Ke Zhou, Monica M Bennett, Carlos H Villa, Kendall P Hammonds, Yun Lu
Plos One. 2022-01-01
78 citations
Low Infection Rate and Long Durability of Nontunneled Silastic Catheters: A Safe and Cost-effective Alternative for Long-term Venous Access
Issam I Raad, Steve Davis, Marilyn Becker, David C. Hohn, Deborah Houston
Archives of Internal Medicine. 1993-08-09

Abstracts/Posters

Low prevalence of key resistance mutations in geographically diverse, therapy naïve, HIV-1 infected subjects in North America
McClernon, DR; Pierce, A; Thompson, M; Kirkland, L; Erbelding, E; Davis, S; St. Clair, M.; and Snidow, J, 4th International Workshop on HIV Drug Resistance and Treatment Strategies
Disseminated Mycobacterium avium infection with multiple nodular skin lesions treated with Clarithromycin
Davis, S; Pate, P; Phaneuf, B., Frontiers in Mycobacteriology, Vail, Colorado
Catheter removal affects recurrence of catheter-related coagulase negative Staphylococcal bacteremia.
Raad, I; Davis, S; Khan, A; Tarrand, J; and Bodey, JP, ASM, Dallas, TX
Line-related infections with rapidly growing mycobacterium
Raad, I; Davis, S; et al, ASM
Cost effectiveness of peripherally inserted central venous catheters in cancer patients
Davis, S; Raad, I; et al., APIC, Nashville, TN
Low infection rate and high durability of non-tunneled silicone central venous catheters in cancer patients
Davis, S; Raad, I; et al., ASM, Dallas
Surgeon/OR Staff Questionnaires to Improve SSI Rates
Davis, S.G.; Allen, B.B.; Luterman, A.E. And Streete, S, SHEA, Dallas, 2011
Join now to see all